Reulay leverages machine learning and mixed reality treatments to reduce stress and anxiety disorders associated with chronic disease
Reulay’s virtual reality therapeutic platform leverages machine learning across biometric, digital behavior, and brain science to personalize evidence-based digital medicine that targets human biology for prevention and treatment. Founded by leading psychiatrists, Reulay is advancing a broad pipeline of products across VR, AR, Mobile, & Web interventions to decrease stress and anxiety disorders, as well as associated chronic medical conditions such as cancer, stroke, heart disease & neurodegenerative diseases.
Learn more about this company on Crunchbase.